Citius Oncology, Inc. CTOR Total Operating Expenses
Total Operating Expenses at other companies
Other financials
Where this comes from
Reported directly by Citius Oncology, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingExpenses.
The official record: Citius Oncology, Inc.’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →
Ask your AI about Citius Oncology, Inc.'s total operating expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Citius Oncology, Inc.'s total operating expenses?
- Citius Oncology, Inc. (CTOR) reported total operating expenses of $29.95M in Q1 2026.
- How has Citius Oncology, Inc.'s total operating expenses changed year-over-year?
- Citius Oncology, Inc.'s total operating expenses increased by 300.9% year-over-year, from $7.47M to $29.95M.
- What is the long-term trend for Citius Oncology, Inc.'s total operating expenses?
- Over 2 years (2023 to 2025), Citius Oncology, Inc.'s total operating expenses has grown at a 39.3% compound annual growth rate (CAGR), from $12.12M to $23.52M.
- What does total operating expenses mean?
- The sum of all operating costs including COGS, SG&A, R&D, D&A, and other operating charges. Revenue minus total operating expenses equals operating income.